MEI Pharma appoints Sujay Kango to board; Kevan Clemens resigns effective Nov 22, 2021

Lite Strategy, Inc.

Kevan Clemens resigned from board effective Nov 22, 2021; no disagreement with company.
Sujay Kango appointed to fill vacancy; 25+ years pharma/biotech experience.
Kango received initial option grant of 25,000 shares vesting over three years.
Kango also received pro-rated annual option grant of 33,334 shares vesting monthly over 12 months.
Kango's expertise includes commercial launches; company aims to transition to commercial stage.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sujay Kango

Director

LITS · Lite Strategy, Inc.

Effective: 2021-11-22
Filed: November 23, 2021, 6:59 PM ET

On November 22, 2021, the Board appointed Mr. Sujay Kango to fill the vacancy on the Board resulting from the vacancy created by the resignation of Mr. Clemens.

Departed

Kevan Clemens

Director

LITS · Lite Strategy, Inc.

Effective: 2021-11-22
Successor: Sujay Kango
Filed: November 23, 2021, 6:59 PM ET

On November 22, 2021, Mr. Kevan Clemens, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) resigned from the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sujay Kango was appointed as Director at Lite Strategy, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 22, 2021, the Board appointed Mr. Sujay Kango to fill the vacancy on the Board resulting from the vacancy created by the resignation of Mr. Clemens.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevan Clemens resigned as Director at Lite Strategy, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 22, 2021, Mr. Kevan Clemens, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) resigned from the Board, effective immediately.

View on SEC.gov

Lite Strategy, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-337594

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.